Synthetic studies for the 1,3-iterative organoiron approach to the synthesis of siculinine: efficient arylation using a diarylcuprate reagent by Stephenson, George et al.
FULL PAPER
DOI: 10.1002/ejoc.200((will be filled in by the editorial staff))

Synthetic studies for the 1,3-iterative organoiron approach to the synthesis of siculinine: efficient arylation using a diarylcuprate reagent
G. Richard Stephenson,*[a] Ian M. Palotai,[a] Sarah Thomas,[a] Michael Tinkl[a]
Dedicated to … on the occasion of … ((optional))
Keywords: Synthesis design / Arylation / C–C coupling / Alkaloids / Regioselectivity / Iron / Copper / Density functional
calculations













	Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/ejoc.xxxxxxxxx.
Introduction
We are developing synthetic methods that employ transition metal centres as stereodominant[1] control groups in reaction sequences that make multiple use[2] of the metal in a series of strategically important bond-formation steps.[3] We have recently described[4] [1,1]-iterative routes to several Amaryllidaceae alkaloids[5] for which an  cation starting point is ideal[6] and methoxy-substituted arylcyclohexadienyliron electrophiles[7] served as key intermediates. (–)-Siculinine (cis BC fusion)[8] and (–)-ungiminorine (trans BC ring fusion)[9] have also been selected as targets in our group, because the oxygenated C rings resemble the high levels of oxygenation found in the far more extensively studied simpler[10] alkaloid pancratistatin (trans ring fusion), which has become a major target for synthesis because of its anticancer activity. For the target molecule (–)-siculinine (Figure 1), we propose to include on the cyclohexadienyl ligand, a methoxy substituent as a control group and 2-ethanoyl ester side-chain to give access to lactam intermediates to introduce the D ring of the target. Approaches of this type need a new procedure for retrosynthetic analysis.[11] Key decisions in forming a synthetic plan are the choice of hapticity (2-7) for the initial metal complex, and the type of reaction sequence (linear or iterative).[12] Examples of possible 4, 5 and 6 electrophiles are shown in Figure 2, and based on the  directing effect of internally positioned OMe groups,[13] the 5 system (e.g. 2a[14] or the ethyl ester 2b) is again a suitable choice.

Figure 1. Retrosynthetic analysis for siculinine and identification of the portion to be introduced as the “working ligand”
Figure 2. Anticipated regiocontrol effects in disubstituted working ligands of prospective cationic 4, 5 and 6 organometallic electrophiles for use in the synthesis of siculinine [in the case of 2a, the site of nucleophile addition (arrow), and the position of the CH2CO2Me substituent, which is itself introduced as a nucleophile (see Scheme 1), are in a 1,3 (i.e. meta) relationship]
The addition of the arene to the working ligand[15] is a key step in the proposed synthetic approach. We have recently described a model study[16] with the required methoxycarbonylmethyl substituent on the cyclohexadienyl ligand and Ph2Zn as the nucleophile, and the fully functionalised organozinc reagent 6 is known[17] to work well with the simple electrophilic tricarbonyl[(1,2,3,4,5-)-2-methoxycyclohexadienyliron(1+)] PF6(1–) complex 9: (“Birch’s salt” [18]). The CH2CO2R-substituted salt 2 needed for (–)-siculinine is a far more difficult example, because the CH2 group beside the ester is highly acidic (it is activated both by the ester and by the dienyl complex[19]) and if basic nucleophiles are used, deprotonation side-reactions will dominate. We describe here[20] a new selective synthesis of 2 (2b, R = Et) from 8 by hydrolysis and a Reformatsky reaction of the resulting neutral dienone complex, and conditions which allow the formation of the aryl adduct 1b in excellent yield.
Results and Discussion
Tricarbonyl[(1,2,3,4-)-1,2-dimethoxycyclohexadiene]iron(0) was prepared on a 20 gm scale by complexation of 1,2-dimethoxycyclohexa-1,4-diene and crystallisation of the crude product from light petroleum. Hydride abstraction and hydrolysis of the mixture of products afforded the cyclohexadienone complex 5. Addition of EtO2CCH2ZnBr[21] and treatment with ethereal tetrafluoroboric acid gave the ethyl ester 2b as the tetrafluoroborate salt, which is accessible by this route without the use of chromatography (Scheme 1). The corresponding methyl ester 2a is available[14] by reaction of 1-trimethylsilyloxy-1-methoxyethene with tricarbonyl[(1,2,3,4,5-)-1,2-dimethoxycyclohexadiene]-iron(1+) hexafluorophosphate(1–) (8).

Scheme 1. a: Fe(CO)5, Bu2O, reflux, 16 h x 3 (recycling), 46%; b: Ph3CPF6, CH2Cl2, reflux, 1 hr, 84% of salt 8 (see Fig. 3); c: hydrolysis of salt 8: H2O, 80 °C, 15 min, 80%; d: EtO2CCH2ZnBr, dioxane, ultrasound, 30 min, 93%; HBF4.OEt2, –50 °C to rt then add to Et2O, 84%.
Figure 3. Organozinc and -copper nucleophiles and organoiron electrophiles used in this study.
It is known from the earlier model study that the reaction between diphenylzinc and salt 2a gives the expected product 1c (Ar = Ph, R = CH2CO2Me) in 54% yield.[16] The exocyclic triene 10, which would arise from completing deprotonation at the highly acidic methylene group beside the ester, was not observed in that experiment.[22] However, because of the possibility of coodination of the zinc by the tertiary amines (vide infra), the fully functionalised organozinc reagent 6 (Figure 3) is a very different type of diarylzinc reagent. When used with the 2-methoxy salt 2a in our earlier work,[17] it gave only traces of the expected arylcyclohexadiene complex. In contrast, when the diarylcuprate reagent 7 was added to the simple 2-methoxy salt 9, the arylated product was formed in 62% yield.[17] Thus at the outset, it seemed likely from these studies that organocopper reagents were superior to the corresponding diarylzinc nucleophiles. Consequently, our study of the arylation of 2a and 2b began with attempts in the organocopper series (Table 1).
Table 1. Comparison of organocopper-mediated arylation of 2 with earlier model studies with diarylzinc reagents
a: R = CH2CO2Me; Ar = (OCH2O)C6H2CH2N(CH2CH=CH2)2
b: R = CH2CO2Et; Ar = (OCH2O)C6H2CH2N(CH2CH=CH2)2
c: R = CH2CO2Me; Ar = Ph
d: H; Ar = (OCH2O)C6H2CH2N(CH2CH=CH2)2

	R	X–	Temp (°C) / additive	Nu (Ar2Mn–)[a]	1      yield         (%)	10[b] (%)	ref.
1	CH2CO2Me	PF6–	0 /none	Ph2Zn;	1c     54	n.o.[c]	[d]
2	H	PF6–	0 / none	6 (M=Zn)[e]	1d   trace	 -	[f]
3	H	PF6–	0 / none	7 (M=Cu)[g]	1d    62	 -	[f]
4	CH2CO2Me	PF6–	0 / none	7 (M=Cu)[g]	1a      9	37	this work
5	CH2CO2Et	BF4–	–100 / DMF	7 (M=Cu)[g]	1b    88	n.o.[h]	this work
[a] “n” indicates the number of negative charges on the organozinc and cuprate reagents (organozinc reagents, n = 0 for a neutral reagent; organocuprate reagents, n = 1 for an anionic reagent) [b] assigned as the E isomer on the basis of a DFT calculation that shows this to be the more stable gas phase configuration; [c] n.o.: not observed; [d] ref. [16]; [e] n = 0; [f] ref. [17]; [g] n = 1; [h] the corresponding ethyl ester was not observed in this experiment (an authentic sample has be prepared by deprotonation of 2b using Hünig’s base).
Scheme 2. a: H2C=CHCH2NH2, NaBH3CN, 4A sieves, MeOH, HCl, rt, 100 h, 55%; b: H2C=CHCH2Br, NaH, DMF, 85 °C, 20 min, 65%; c) n-BuLi, Et2O,  –78 °C then rt, CuBr, THF, –78 °C then 0 °C, 2 min.
The aryllithium reagent that is required to form the organocuprate nucleophile 7 is known from a synthesis of cripowellins in Enders’ group, though in our case (Scheme 2) we made the precursor aryl bromide 12 by a different method to Enders[23] who started from a benzyl amine that had been employed by Miranda and Zard[24] to make (±)--lycorane. In our work, we used allylamine in a reductive amination (Scheme 2) of 6-bromopireronal 11 followed by an allylation reaction with sodium hydride and allyl bromide in DMF. In the hexafluorophosphate series (Table 1), the cuprate 7 was generated from CuBr in THF, but gave poor results as 1a was only obtained in only 9 % yield. The major product was triene complex 10 (37% yield). 
The problem was solved by reaction of the tetrafluoroborate salt 2b with an organocuprate reagent generated at –30 °C from CuBr.SMe2. The diarylcuprate reagent was then cooled to –100 °C, before addition of the cyclohexadienyliron complex. After 30 minutes at –100 °C the reaction mixture was allowed to warm to 0 °C and then worked up after a further 2 minutes. The required product 1b was obtained in 88% yield. 
                        a                                b
Figure 4. Conformations of {[R2NCH2C6H2(OCH2O)]2M}n–: R- = Me- or H2C=CHCH2-; M = Zn, n = 0 (a) and Cu, n = 1 (b) (Gaussian09/3blyp/Lan2DZ) (minima confirmed by frequency calculations)
Diarylzinc reagents of type 6 (e.g. Ar2Zn; Ar = 2-C6H4CH2NEt2) are known to form chelate rings by intramolecular coordination of the central zinc atom by the amine nitrogens, and the corresponding diarylmercury chelate complex has been crystallographically characterised.[25] A related arylcopper reagent (ArCu; Ar = 2-CHMeNMe2-5-MeC6H3) has also been characterised in the solid state and is a tetramer with a square of four copper atoms at its core.[26] In the diarylcuprate series (e.g. Ar2Cu(CN)Li2; Ar = 2-C6H4CH2NMe2), however, intermolecular rather than intramolecular coordination appears to dominate and linear chain structures have been characterised in the solid state.[27] In the cyanocuprate case, the cyanide anion plays an important role in the chain structure. To gain a better understanding of the difference in reactivity between the diarylzinc and diarylcuprate structures 6 and 7, optimized gas phase geometries for the monomeric forms have been determined by DFT calculation using Gaussian09/3blyp and the basis set Lan2DZ. To simplify conformational issues, dimethylamino groups were used in place of the diallyl amines. The neutral diarylzinc structure was bent with an Ar-Zn-Ar angle of about 154° and the nitrogen atoms of the NMe2 groups close to the zinc (2.3 Å). In contrast, the anionic diarylcuprate was almost linear (179°) and the NMe2 groups were more distant from the metal [3.7 Å, which is greater than the sum of the van der Waals radii[28] (2.79 Å)]. Representative conformations of 6 and 7 were also examined and showed similar structural properties (Table 2). The HOMOs and nearby orbitals (Figure 5) for the two nucleophiles show significant differences. The HOMO is ligand-centred in the neutral organozinc reagent (Figure 5a) but metal-centred in the anionic organocuprate (Figure 5e). In the zinc case, it is necessary to look down as far as HOMO-3 (Figure 5d) to find the metal-centred MO which is distorted by the bent form of the structure.
On this basis, we propose that the intramolecular coordination in the diarylzinc reagents (reported in the solid state,[25] and confirmed by our calculations) hinders their reactions with electrophilic cyclohexadienyliron(1+) complexes, and that although the reaction with 2a was successful with the simple organozinc reagent Ph2Zn (Table 1, entry 1), it fails when intramolecular coordination of the zinc by benzylic amine functionality on the arene is present (Table 1, entry 2). The organozinc series of nucleophiles are unsuitable for our intended application in a synthesis of siculinine. In the diarylcuprate series, competing deprotonation[29] of the sensitive methylene group between the cationic dienyliron complex and the ester can in some cases reduce the yield of the desired intermediates of type 1 (Table 1, entry 4), but conditions have been identified (Table 1, entry 5) under which the reaction is successful.






[a] calculated with a representative conformation of the allyl groups.
Figure 5. HOMO, HOMO–1, HOMO–2, HOMO–3, of {[Me2NCH2C6H2(OCH2O)]2M}n– (Gaussian09/3blyp/Lan2DZ): a-d: M =Zn, n = 0; e-g: M = Cu, n = 1; h (calculated for a representative conformation of {[(H2C=CHCH2)2N]CH2C6H2(OCH2O)]2Cu}– 7 [see Figures 3 and 4b (lower row)].
Conclusions
A successful procedure has been developed to prepare a proposed intermediate 1 using an organocuprate reagent to effect efficient arylation of the base-sensitive electrophilic cyclohexadienyliron complex 2b.
Experimental Section
Tricarbonyl[(1,2,3,4,5-)-1-ethoxycarbonylmethyl-2-methoxycyclohexadienyl]iron(l+) tetrafluoroborate(l–) (2b): Ethyl -bromoacetate (13.2 mL, 0.12 M), activated zinc copper couple (6.3 g) and iodine (2.54 g, 0.01 M) were added to a solution of tricarbonyl[(2,3,4,5-)-2-methoxycyclohexadiene-l-one]iron(0) (5) (13.2 g, 0.05 M) in dioxane (50 mL). The mixture was sonicated for 30 min and poured into ice/water (40 mL). After filtration through Celite, the solution was extracted with dichloromethane (3 x 100 mL). The combined extracts were dried (MgSO4) and the solvent was removed by rotary evaporation. Column chromatography (40/60 petroleum ether / diethyl ether gradient) afforded tricarbonyl[(2,3,4,5-)-1-hydroxy-l-ethoxycarbonylmethyl-2-methoxy-2,4-cyclohexadiene]iron(0) (16.43 g, 93%) as a yellow oil. A portion of the product (1.66 g, 0.47 mM) was dissolved in dichloromethane (35 mL) and cooled to –50 °C. Ethereal tetrafluoroboric acid (3.3 m1, 50%) was added. The solution was allowed to warm to room temperature and transferred dropwise into dry diethyl ether (100 mL). Filtration afforded tricarbonyl[(1,2,3,4,5-)-1-ethoxycarbonylmethyl-2-methoxycyclohexadienyl]iron(l+) tetrafluoroborate(l–) (2b) (1.67g, 84%) as a yellow powder. 1H NMR (250 MHz, CD3CN):  = 6.96 (d, 3J3,4 6.0, 1H, 3-H), 5.84 (dd, 3J3,4 6.0, 3J4,5 6.5, 1H, 4-H), 4.32 (t, 3J4,5 6.5, 3J5,6 6.5, 1H, 5-H), 4.11 (q, J 7.5, 2H, OCH2), 4.05 (s, 3H, OMe), 3.11-2.85 (m, 3H, 6-H, CH2CO2), 2.32 (d, 3J6,6 15.3, 1H, 6-H), 1.21 (t, 3J 7.5, 3H, CH3). 13C NMR (62.9 MHz):  = 169.09 (C=O), 98.16 (4-C), 72.77 (3-C), 66.92 (5-C), 62.17 (OCH2), 58.44 (OMe), 56.65 (1-C), 37.68 (CH2CO2), 33.25 (6-C), 14.35 (CH3). IR (acetonitrile): max = 2111, 2060 (C≡O) cm–1. Elemental analysis calcd (%) for C14H15BF4FeO6 (421.92): C 39.85, H 3.6; found: C 39.9, H 3.5. Tricarbonyl[(1,2,3,4,5-)-1-ethoxycarbonylmethyl-2-methoxycyclohexadienyl]iron(l+) hexafluorophosphate(l–) IR (acetonitrile) max = 2114, 2048 (C≡O) cm–1. Elemental analysis calcd (%) for C14H15F6FeO6P (480.08) C 35.0, H 3.15; found C 35.3, H 3.0.) was obtained by precipitation from water by addition of saturated aqueous ammonium hexafluorophosphate.

Tricarbonyl[(2,3,4,5-)-1-ethoxycarbonylmethylidene-2-methoxy-2,4-cyclohexadienylideneliron(0) (10b): N,N-Diisopropylethylamine (0.94 mL, 5,4 mM) was added to a suspension of tricarbonyl[(1,2,3,4,5-)-1-ethoxycarbonylmethyl-2-methoxycyclohexadienyl]iron(l+) tetrafluoroborate(l–) (2b) (2.08 g, 4.9 mM) and water (100 mL) and heated  at 80 °C for 10 min. After cooling the mixture was extracted with diethyl ether (2 x 100 mL). The combined extracts were dried (MgSO4) and the solvent removed by rotary evaporation. Column chromatography (10% ether/40/60 petroleum ether) afforded afforded tricarbonyl[(2,3,4,5-)-1-ethoxycarbonylmethylidene-2-methoxy-2,4-cyclohexadienylidene]iron(0) (10) (1.10 g, 67%) as an orange solid. M.p. 51.5-52.5 °C. 1H NMR (250 MHz, CDCl3):  = 5.76 (dd, 3J3,4 5.6, 1.5, 1H, 3-H), 5.70 (s, 1H, methylidene), 5.23 (t, 3J3,4 5.6, 3J4,5 5.6, 1H, 4-H), 4.10 (q, 3JH,H 7.0, 2H, OCH2), 3.53 (s, 3H, OMe), 2.83-3.27 (m, 3H, 5-H, 6-H), 1.26 (t, 3JH,H 7.0, 3H, Me). 13C NMR (62.9 MHz):  = 211.0 (CO), 166.5 (C=O), 153.8 (2-C), 113.5 (1-C), 107.9 (7-C), 80.8, 78.4 (3-C, 4-C), 59.6 (OMe). 59.6 (OCH2), 56.0, (5-C), 32.2 (6-C), 14.3 (CH3). IR (dichloromethene): max. = 2050, 1980 (C≡O), 1761 (C=O) cm–1. Elemental analysis calcd (%) for C14H14FeO6 (334.10): C 50.3, H 4.2; found: C 50.5, H 4.2.

Tricarbonyl[(2,3,4,5-)-2-methoxy-1-(methoxycarbonylmethylidene)cyclohexa-1,3-diene]iron(0) (10a) and tricarbonyl[(l,2,3,4-)-2-methoxy-1-(methoxycarbonylmethy1)-5,-(6-N,N-diallylaminomethyl-3,4-methylenedioxy)phenylcyclohexa-1,3-diene]iron(0) (1a): n-Butyllithium (0.85 mL of a 1.33 M solution in hexane, 1.13 mmol) was added to a solution of 6-bromo-N,N-diallylpiperonylamine (12) (349 mg, 1.12. mmol) in diethyl ether (10 mL) at –78 °C. After 5 min the solution was allowed to warm to rt and then was cooled again to –78 °C and CuBr (81.2 mg, 0.56 mmol) in THF (10 ml) was added. The mixture was allowed to warm to 0 °C over 15 min. Tricarbonyl[(1,2,3,4,5-)-1-methoxycarbonylmethyl-2-methoxycyclohexadienyl]iron(l+) hexafluorophosphate(l–) (2a) (204 mg, 0.44 mmol) was added at 0 °C and after 2 min, 10% aqueous ammonium chloride solution (20 mL) was added and the organic phase was removed. The aqueous phase was extracted with diethyl ether (3 x 80 mL). The combined organic layers were washed with water (2 x 80 mL) and then brine (2 x 80 mL) and dried (K2CO3). After filtration, the solvent was evaporated under reduced pressure to give a brown oil. Chromatography on silica eluting with 40% dichloromethane in petrol gave tricarbonyl[(2,3,4,5-)-2-methoxy-1-(methoxycarbonylmethylidene)cyclohexa-1,3-diene]iron(0) (10) (51 mg, 37%) m.p. 61-63 °C. 1H NMR (400 MHz; CDCl3):  = 5.77 (dd, 3J3,4 4.6, 4J3,5 1.5, 1H, 3-H), 5.72 (m, 1H, methylidine), 5.23 (ddt, 3J4,5 6.5, 3J3,4 4.6, 4J4,6 1.0, 1H, 4-H), 3.66 (s, 3H, OMe), 3.53 (s, 3H, OMe), 3.22 (dm, 3J6,6 19.3, 1H, 6-H), 3.11 (m, 1H, 4-H), 2.87 (dm, 3J6,6 19.3, 1H, 6-H). IR (C6H12) max. = 2050, 1986, 1983 (C≡O); 1718 (C=O), 1620 cm–1. MS (EI): m/z (%) = 320 (M+, 1), 292 (M+–CO, 26), 264 (M+–2CO, 19), 236 (M+–3CO, 100). HRMS (CI): m/z: calcd. for C13H13FeO6: 321.0062; found 321.0060 for [M + H]+. The column was then eluted with methanol to remove all remaining material. The material recovered was purified by flash chromatography on silica (E. Merck No. 9385) eluting with 5% ethyl acetate in petrol to give tricarbonyl[(l,2,3,4-)-2-methoxy-1-(methoxycarbonylmethy1)-5-(6-N,N-diallylaminomethyl-3,4-methylenedioxy)phenylcyclohexa-1,3-diene]iron(0) (1a) (21 mg, 9%), 1H NMR (400 MHz; CDCl3):  = 6.67 (s, 1H, ArH), 6.64 (s, 1H, ArH), 5.90 (d, 2JH,H 1.5, 1H, OCH2O), 5.88 (d, 2JH,H 1.5, 1H, OCH2O), 5.85 (m, 2H, =CH), 5.16 (m, 4H, =CH2), 5.07 (d, 3J3,4 6.7, 1H, 3-H), 3.77 (s, 3H, OMe), 3.70 (dt, 3J5,6 11.0, 3J4,5 3.7, 3J5,6 3.7, 1H, 5-H), 3.71 (s, 3H, OMe), 3.42 (d, 2JH,H 13.1, 1H, ArCH2), 3.31 (d, 2JH,H 13.1, 1H, ArCH2), 3.04 (ddm, 2JH,H 14.0, 3JH,H 6.1, 2H, NCH2), 3.02 (s, 2H, CH2CO2), 2.95 (ddm, 2JH,H 14.0, 3JH,H 6.4 Hz, 2H, NCH2), 2.73 (dd, 3J3,4 6.7, 3J4,5 3.7, 1H, 4-H), 2.42 (dd, 3J6,6 15.0, 3J5,6 11.0, 1H, 6-H), 1.72 (dd, 3J6,6 15.0, 3J5,6 3.7, 1H, 6-H). 13C NMR (100 MHz; CDCl3):  = 211.2 (Fe(CO)3), 171.3 (-CO2), 146.9 (3’- or 4'-C), 145.1 (4’- or 3’-C), 140.0 (2-C), 139.1 (1’-C), 135.8 (CH=), 129.5 (6’-C), 117.5 (=CH2), 106.6 (2’-C), 100.8 (OCH2O), 110.7 (5’-C), 65.8 (1-C), 63.4 (3-C), 56.3 (NCH2 and ArCH2), 56.2 (4-C), 54.7 (OMe), 51.7 (ester OMe), 39.3 (6-C or CH2CO2), 39.0 (5-C), 38.6 (6-C or CH2CO2). IR (C6H12): max. = 2048, 2042, 1985, 1975, 1967 (C≡O), 1748 (C=O) cm–1. MS (DCI-MS; NH3, negative ion spectrum): m/z (%) = 551 (M–, 16), 523 (M––CO, 100). HRMS (CI): m/z: calcd. for C27H29FeNO8: 551.1243; found m/z 551.1240.

Tricarbonyl[(l,2,3,4-)-2-methoxy-1-(ethoxycarbonylmethy1)-5,-(6-N,N-diallylaminomethyl-3,4-methylenedioxy)phenylcyclohexa-1,3-diene]iron(0) (1b): A solution of 6-bromo-N,N-diallylpiperonylamine (12) (1.00 g, 3.22 mmol) in dry THF (30 mL) was cooled to –78 °C and a solution of n-butyllithium in hexanes (1.90 mL, 2.90 mmol) was added over a period of 1 min. The reaction mixture turned from colourless to orange and was stirred for 1 h at –78 °C. Copper(I) bromide-dimethyl sulfide complex (268 mg, 131 mmol) was as added in one portion and the resulting mixture was warmed to –30 °C and stirred at this temperature for a further 5 min. The mixture was then cooled to –100 °C and tricarbonyl[(1,2,3,4,5-)-1-ethoxycarbonylmethyl-2-methoxycyclohexadienyl]iron(l+) tetrafluoroborate(l–) (2b) (367 mg, 0.87 mmol) was added in one portion. The resulting suspension was stirred for 30 min at –100 °C. After warming to 0 °C, the solution was stirred for a further 2 min, during which time the suspended solids were consumed. The resulting brown solution was poured into a separating funnel charged with saturated aqueous ammonium chloride (50 mL) and ethyl acetate (30 mL). Extraction with ethy1 acetate (3 x 100 mL) and evaporation under reduced pressure gave a brown liquid (1.23 g) which was purified by column chromatography on silica eluting with ethy1 acetate - hexane (1:5 v:v) to give tricarbonyl[(l,2,3,4-)-2-methoxy-1-(ethoxycarbonylmethy1)-5-(6-N,N-diallylaminomethyl-3,4-methylenedioxy)phenylcyclohexa-1,3-diene]iron(0) (1b) (471 mg, 88%) as a yellow gum, Rf = 0.20 (SiO2, 1:5 EtOAc / hexane). 1H NMR (400 MHz; CDCl3):  = 6.67 (s, 1H, ArH), 6.64 (s, 1H, ArH), 5.88 (br m, 4H, CH= and OCH2O), 5.17 (m, 4H, =CH2), 5.06 (d, 3J3,4 6.9, 1H, 3-H), 4.17 (q, 3JH,H 7.2, 2H, OCH2), 3.77 (s, 3H, OMe), 3.69 (dt, 3J5,6 11.2, 3J4,5 3.6, 3J5,6 3.6, 1H, 5-H), 3.43 (d, JH,H 12.9, 1H, ArCH2), 3.31(d, JH,H 12.9. 1H, ArCH2), 3.01 (s, 2H, CH2CO2), 2.99 (m, 4H, N-CH2), 2.73 (dd, 3J3,4 6.6, 3J4,5 3.6, 1H, 4-H), 2.44 (dd, 3J6,6 14.9, 3J5,6 11.2, 1H, 6-H), 1.75 (dd, 3J6,6 15.2, 3J5,6 3.6, 1H, 6-H), 1.29 (t, 3JH,H 6.9, 3H, Me). IR (CDC13): max = 2043, 1974 (C≡O), 1730 C=O cm–1. MS (EI): m/z (%) = 565 (0.3, M+), 537 (4, M+–CO), 509 (2, M+–2CO), 481 (67,M+–3CO), 479 (83, M+–3CO–H2), 440 (54), 423 (3, M+–3CO–H2–Fe), 394 (46) 328 (33), 287 (72), 245 (100), 223 (64), 203 (37), 192 (38), 135 (97), 121 (24), 96 (45), 91 (23), 77 (21). Elemental analysis calcd (%) for C28H31FeNO8 (565.40): C 59.5; H 5.5; N 2.5; found: C 59.5; H 5.5; N 2.8.

Supporting Information (see footnote on the first page of this article): … . Full experimental details, 1H NMR and 13C NMR spectra for key compounds, details of optimised structures from DFT calculations.
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